Persistent serotype 3 and 19A invasive pneumococcal diseases in adults in vaccine era: Serotype-dependent difference in ceftriaxone susceptibility-Reference-Cited by-同舟云学术

Persistent serotype 3 and 19A invasive pneumococcal diseases in adults in vaccine era: Serotype-dependent difference in ceftriaxone susceptibility

Published:2022-04 Issue:15 Volume:40 Page:2258-2265
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Yoon Jin Gu,Jang A-Yeung,Kim Min Ja,Seo Yu Bin,Lee Jacob,Choi Young Hwa,Kim Young Keun,Jeong Eun Joo,Kim Hyun Soo,Kwon Ki Tae,Jung Dong Sik,Choi Won Suk,Lee Jin Soo,Park Kyung Hwa,Jeong Hye Won,Baik Seung hee,Kang Seong Hui,Bae In-Gyu,Noh Ji Yun,Cheong Hee Jin,Kim Woo Joo,Song Joon Young

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference39 articles.

1. Pneumococcal infection in adults: burden of disease;Drijkoningen;Clin Microbiol Infect,2014

2. Understanding the burden of pneumococcal disease in adults;Blasi;Clin Microbiol Infect,2012

3. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates;O'Brien;Lancet,2009

4. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995–1998: Opportunities for prevention in the conjugate vaccine era;Robinson;JAMA,2001

5. Clinical implications of pneumococcal serotypes: invasive disease potential, clinical presentations, and antibiotic resistance;Song;J Korean Med Sci,2013

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phenotypic and molecular characterization of Streptococcus pneumoniae serotype 3 isolates from blood and respiratory samples in Canada: CANWARD 2007–21;Journal of Antimicrobial Chemotherapy;2024-08-02

2. Impact of Demographic Developments and PCV13 Vaccination on the Future Burden of Pneumococcal Diseases in Germany—An Integrated Probabilistic Differential Equation Approach;Mathematics;2024-03-08

3. Cost-effectiveness of the 20-valent pneumococcal conjugate vaccine versus the 23-valent pneumococcal polysaccharide vaccine for older adults in South Korea;Vaccine;2024-02

4. Recommendations for Adult Immunization by the Korean Society of Infectious Diseases, 2023: Minor Revisions to the 3rd Edition;Infection & Chemotherapy;2024

5. The vaccination of the aged in post COVID-19 era;Journal of Geriatric Neurology;2023-12-15